Updated:
CEB
CEB, or Centre Européen de Biotechnologie, is a French company founded in 1982. It specialises in plastic manufacturing for the biotechnology sector.
CEB
CEB, or Centre Européen de Biotechnologie, is a French company founded in 1982. It specialises in plastic manufacturing for the biotechnology sector. CEB offers design-to-production services with catalog and custom options for various applications.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Beaucouzé
Corporate office
Arlington, VA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at CEB?
No named principals or investment committee members are publicly known for this firm (public record search). No SEC Form ADV, press releases, or professional biographies identify any decision-maker.
What is CEB's investment strategy or asset-class mix?
No strategy documentation exists in public sources. The firm's website, if any, is not indexed in public business registries with investment descriptions. No known media coverage describes its investment approach.
Does CEB participate in fund commitments or direct investments?
The firm has no publicly recorded fund commitments, direct deals, or co-investments traceable in SEC filings, news archives, or industry databases.
What sectors or geographies does CEB focus on?
Sector preferences and geographic focus have not been disclosed. The only known location is Arlington, Virginia (public record).
How is CEB related to the corporate advisory firm CEB (now Gartner)?
No connection is verifiable. The former publicly traded CEB Inc. was acquired by Gartner in 2017. The Arlington-based entity CEB referenced here has no confirmed link to that predecessor company.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: